BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 29649321)

  • 1. Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
    Kim MJ; Hur BY; Lee ES; Park B; Joo J; Kim MJ; Park SC; Baek JY; Chang HJ; Kim DY; Oh JH
    PLoS One; 2018; 13(4):e0195815. PubMed ID: 29649321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Simultaneous Integrated Boost Intensity Modulated Radiation Therapy (SIB-IMRT) and Non-Operative Strategy on Outcomes of Distal Rectal Cancer Patients with Clinically Positive Lateral Pelvic Lymph Node.
    Li S; Geng J; Wang L; Teng H; Wang Z; Zhu X; Zhang Y; Wang H; Li Y; Cai Y; Wu A; Wang W
    Cancer Manag Res; 2021; 13():537-546. PubMed ID: 33519233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial?
    Sammour T; Chang GJ
    Ann Gastroenterol Surg; 2018 Sep; 2(5):348-350. PubMed ID: 30238075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting lateral pelvic lymph node metastasis based on magnetic resonance imaging before and after neoadjuvant chemotherapy for patients with locally advanced lower rectal cancer.
    Sekido Y; Nishimura J; Fujino S; Ogino T; Miyoshi N; Takahashi H; Uemura M; Haraguchi N; Hata T; Matsuda C; Mizushima T; Murata K; Hasegawa J; Mori M; Doki Y
    Surg Today; 2020 Mar; 50(3):292-297. PubMed ID: 31595366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who Should Get Lateral Pelvic Lymph Node Dissection After Neoadjuvant Chemoradiation?
    Malakorn S; Yang Y; Bednarski BK; Kaur H; You YN; Holliday EB; Dasari A; Skibber JM; Rodriguez-Bigas MA; Chang GJ
    Dis Colon Rectum; 2019 Oct; 62(10):1158-1166. PubMed ID: 31490825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.
    Ogura A; Konishi T; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Beets GL; Rutten HJT; Kusters M;
    J Clin Oncol; 2019 Jan; 37(1):33-43. PubMed ID: 30403572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive factors of pathological lateral pelvic lymph node metastasis in patients without clinical lateral pelvic lymph node metastasis (clinical stage II/III): The analysis of data from the clinical trial (JCOG0212).
    Komori K; Fujita S; Mizusawa J; Kanemitsu Y; Ito M; Shiomi A; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bandou H; Katsumata K; Kinugasa Y; Takii Y; Akasu T; Moriya Y;
    Eur J Surg Oncol; 2019 Mar; 45(3):336-340. PubMed ID: 30477950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-operative Evaluation of Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer: Comparison of Three Different Imaging Modalities.
    Amano K; Fukuchi M; Kumamoto K; Hatano S; Ohno H; Osada H; Ishibashi K; Ishida H
    J Anus Rectum Colon; 2020; 4(1):34-40. PubMed ID: 32002474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.
    Hashiguchi Y; Muro K; Saito Y; Ito Y; Ajioka Y; Hamaguchi T; Hasegawa K; Hotta K; Ishida H; Ishiguro M; Ishihara S; Kanemitsu Y; Kinugasa Y; Murofushi K; Nakajima TE; Oka S; Tanaka T; Taniguchi H; Tsuji A; Uehara K; Ueno H; Yamanaka T; Yamazaki K; Yoshida M; Yoshino T; Itabashi M; Sakamaki K; Sano K; Shimada Y; Tanaka S; Uetake H; Yamaguchi S; Yamaguchi N; Kobayashi H; Matsuda K; Kotake K; Sugihara K;
    Int J Clin Oncol; 2020 Jan; 25(1):1-42. PubMed ID: 31203527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis.
    Zhou S; Jiang Y; Liang J; Liu Q
    World J Surg Oncol; 2022 Mar; 20(1):97. PubMed ID: 35351137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncological Impact of Lateral Lymph Node Dissection After Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
    Kim MJ; Chang GJ; Lim HK; Song MK; Park SC; Sohn DK; Chang HJ; Kim DY; Park JW; Jeong SY; Oh JH
    Ann Surg Oncol; 2020 Sep; 27(9):3525-3533. PubMed ID: 32385767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on the management of lateral pelvic lymph nodes in rectal cancer.
    Chua JYJ; Ngu JCY; Teo NZ
    World J Clin Oncol; 2023 Dec; 14(12):584-592. PubMed ID: 38179407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis.
    Zeng DX; Yang Z; Tan L; Ran MN; Liu ZL; Xiao JW
    Front Oncol; 2023; 13():1219608. PubMed ID: 37746256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical implication and management of rectal cancer with clinically suspicious lateral pelvic lymph node metastasis: A radiation oncologist's perspective.
    Yoo GS; Park HC; Yu JI
    Front Oncol; 2022; 12():960527. PubMed ID: 36568216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based radiomics to predict neoadjuvant chemoradiotherapy outcomes in locally advanced rectal cancer: A multicenter study.
    Xiang Y; Li S; Wang H; Song M; Hu K; Wang F; Wang Z; Niu Z; Liu J; Cai Y; Li Y; Zhu X; Geng J; Zhang Y; Teng H; Wang W
    Clin Transl Radiat Oncol; 2023 Jan; 38():175-182. PubMed ID: 36471751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection.
    Crafa F; Vanella S; Catalano OA; Pomykala KL; Baiamonte M
    World J Gastroenterol; 2022 Aug; 28(30):4019-4043. PubMed ID: 36157105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and External Validation of a Preoperative Nomogram for Predicting Lateral Pelvic Lymph Node Metastasis in Patients With Advanced Lower Rectal Cancer.
    Zhang L; Shi F; Hu C; Zhang Z; Liu J; Liu R; She J; Tang J
    Front Oncol; 2022; 12():930942. PubMed ID: 35880161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant improvement after training in the assessment of lateral compartments and short-axis measurements of lateral lymph nodes in rectal cancer.
    Sluckin TC; Hazen SJA; Horsthuis K; Lambregts DMJ; Beets-Tan RGH; Tanis PJ; Kusters M;
    Eur Radiol; 2023 Jan; 33(1):483-492. PubMed ID: 35802179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does neoadjuvant chemoradiotherapy increase the effect of lateral lymph node dissection on urogenital function?
    Jiang Y; Zhou S; Pei W; Chen J; Liang J
    Transl Cancer Res; 2022 Apr; 11(4):784-795. PubMed ID: 35571646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.